November 18, 2026
Health news, explained with evidence
LIVE

Karolinska Institutet Thesis Explores Making Tumor Cells Easier for T Cells to Recognize

🧠 AI Analysis 2 min read 👁 4

A doctoral thesis from Karolinska Institutet investigates altering tumor-cell mechanisms to improve immune recognition and help T cells target cancer cells more effectively.

Karolinska Institutet Thesis Explores Making Tumor Cells Easier for T Cells to Recognize🧠AI Analysis

Photo: Medical Xpress

Key points

  • Thesis at Karolinska Institutet investigated making tumor cells easier for T cells to recognize
  • Blocking BET proteins and PIKfyve improved immune recognition in laboratory models
  • Research remains preclinical; further clinical studies are required

Targeting Tumor-Intrinsic Mechanisms for Better Immunotherapy

Immunotherapy has revolutionized oncology, yet many patients fail to achieve long-term remission because malignancies frequently discover ways to evade immune surveillance. In his doctoral thesis presented on October 23, researcher Lucas Baldran at the Department of Oncology-Pathology explored whether modifying internal tumor-cell processes could enhance their visibility to tumor-specific T cells. Supervised by Jeroen Melief, the research investigated three distinct biological pathways that influence how effectively the immune system detects and attacks cancer cells.

The findings, derived from experiments utilizing patient-derived cells, laboratory models, and a mouse model of metastatic cancer, point to potential new avenues for enhancing treatment efficacy. In the initial study, blocking BET proteins made melanoma cells significantly easier for T cells to identify. A subsequent investigation demonstrated that inhibiting these proteins also boosted the cells' response to antiviral signaling, which further improved T cell recognition when combined with antiviral defense activation. A third study examined PIKfyve, a protein tied to cellular recycling; inhibiting this target made both melanoma and sarcoma cells more vulnerable to immune attack and was linked to limited tumor spread in metastatic mouse models.

"Much of cancer immunotherapy focuses on strengthening the immune response. In this thesis, we asked a different question: can we make tumor cells themselves easier for T cells to recognize and attack?" said Lucas Baldran.

While these experimental findings suggest that altering gene regulation, antiviral signaling, and cellular recycling may help overcome immune evasion, the work remains in early-stage laboratory modeling. Experts note that additional research is required before these insights can translate into clinical therapies for patients. What to know: This preclinical research highlights potential methods to make cancer cells more recognizable to the immune system, but it does not represent an immediate clinical cure or personal treatment. Always consult a qualified physician regarding individual medical care and decisions.

Source Medical Xpress — medicalxpress.com/news/2026-11-tumor-cells-easier.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.